You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resected early stage Non-small Cell Lung Cancer

Showing 9926 - 9950 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Evaluation of OE-MRI in Patients With H&N Cancer

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Oxygen Enhanced MRI scan
  • Nottingham, Nottinghamshire, United Kingdom
    Queens Medical Centre
Sep 30, 2022

Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

Recruiting
  • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Dec 13, 2022

Patterns and Associated Outcomes in Patients of China With

Not yet recruiting
  • HER2-positive Breast Cancer
  • Electronic medical record and hospital information system or other available resources
  • Beijing, China
  • +6 more
Mar 3, 2023

Solid Tumor Trial in Guangzhou, Tianjin (CBP-1018)

Not yet recruiting
  • Solid Tumor
  • Guangzhou, Guangdong, China
  • +1 more
Jun 15, 2021

Breast Cancer Trial in Qingdao (HS-IT101)

Not yet recruiting
  • Breast Cancer
  • HS-IT101
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Aug 16, 2022

Metastatic Clear Cell Renal Cell Carcinoma Trial in Dallas (IL-2, Stereotactic Ablative Body Radiation Therapy)

Completed
Has Results
  • Metastatic Clear Cell Renal Cell Carcinoma
  • IL-2
  • Stereotactic Ablative Body Radiation Therapy
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jul 28, 2021

Lung Transplant; Complications Trial in Durham (Fluoroscopic chest imaging with 4Dx technology software analysis)

Completed
  • Lung Transplant; Complications
  • Fluoroscopic chest imaging with 4Dx technology software analysis
  • Durham, North Carolina
    Duke University
Jul 27, 2022

Parkinson Disease, Freezing of Gait Trial in Beijing (Vibrotactile foot device (Smart shoe))

Recruiting
  • Parkinson Disease
  • Freezing of Gait
  • Vibrotactile foot device (Smart shoe)
  • Beijing, China
    Xuanwu Hospital
Nov 21, 2023

Malaria,Falciparum, Parasitemia, Protozoan Infections Trial in Antwerpen (Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet,

Completed
Has Results
  • Malaria,Falciparum
  • +3 more
  • Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet
  • PfSPZ-DVI Challenge
  • Antwerpen, Belgium
    SGS Belgium NV Clinical Pharmacology Unit
Sep 3, 2021

Prone Position, Acute Respiratory Distress Syndrome Trial in Rome (supine position, prone position)

Not yet recruiting
  • Prone Position
  • Acute Respiratory Distress Syndrome
  • supine position
  • prone position
  • Rome, Italy
    Giorgio Conti
Aug 28, 2023

Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,

Recruiting
  • Oligometastatic Prostate Carcinoma
  • +2 more
  • Placebo Administration
  • +3 more
  • Decatur, Illinois
  • +2 more
Aug 11, 2022

Liver Transplantation, Erythrocyte Transfusion Trial in Rome (Red Blood Cell concentrates from organ donor)

Not yet recruiting
  • Liver Transplantation
  • Erythrocyte Transfusion
  • Red Blood Cell concentrates from organ donor
  • Rome, Italy
    Fondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

NSCLC Trial in Shanghai (sublobar resection, lobectomy)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • sublobar resection
  • lobectomy
  • Shanghai, Shanghai, China
    Shanghai Zhongshan Hospital
Sep 5, 2018

ALK-Positive Large B-Cell Lymphoma, Burkitt-Like Lymphoma With 11q Aberration, DLBCL Activated B-Cell Type Trial in United

Active, not recruiting
  • ALK-Positive Large B-Cell Lymphoma
  • +34 more
  • Phoenix, Arizona
  • +32 more
Jan 3, 2023

MDS Trial in United States (Pracinostat, Azacitidine)

Terminated
Has Results
  • Myelodysplastic Syndromes
  • Duarte, California
  • +24 more
Feb 4, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Pelareorep
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 26, 2022

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jan 3, 2023

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Jacksonville, Florida
  • +11 more
Jan 12, 2023

Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

Recruiting
  • Advanced Breast Cancer
  • TQB3909 tablets
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Mar 16, 2023

Cognitive Impairment in Non-central Nervous System Cancer

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Saint-Louis Lille Battery (SSLIB)
  • (no location specified)
Mar 6, 2023

Biology of Skin Neurofibromas in Neurofibromatosis Type 1

Completed
  • Neurofibromatosis Type 1
  • Neurofibroma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • CD19/CD22-bispecific CAR-T cells
    • Beijing, Beijing, China
      Liang Wang
    Oct 7, 2023

    Breast Cancer Trial (Arm I (No PMRT), Arm II (PMRT))

    Not yet recruiting
    • Breast Cancer
    • Arm I (No PMRT)
    • Arm II (PMRT)
    • (no location specified)
    Aug 8, 2023

    EGFRI Induced Acneiform Lesions Trial in Israel, United States (LUT014 Gel (Dose 1), LUT014 Gel (Dose 2), Placebo)

    Recruiting
    • EGFRI Induced Acneiform Lesions
    • LUT014 Gel (Dose 1)
    • +2 more
    • Glendale, California
    • +15 more
    Dec 29, 2022